LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
Illinois IL
Legislatures
2023-2024 Regular Session
Senate
Bills
SB3491
IL
Illinois Senate Bill SB3491
Illinois 2023-2024 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
IL
Illinois 2023-2024 Regular Session
Illinois Senate Bill SB3491
Introduced
2/9/24
Refer
2/9/24
Caption
CONT SUB-CHRONIC PAIN TREATMEN
Latest IL SB3491 Activity
View All Events: IL 2023-2024 Regular Session SB3491
Companion Bills
No companion bills found.
Previously Filed As
IL SB190
AN ACT relating to chronic pain treatments.
IL HB506
AN ACT relating to chronic pain treatments.
IL H0353
Sickle Cell Disease Treatment of Pain Continuing Education
IL A01921
Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.
IL S03185
Provides outpatient insurance coverage for non-pharmacological treatments and non-opioid drugs for chronic pain.
IL H4165
Non-opiod Pain Management
IL HB1540
CONTROLLED SUB-SCHEDULE II
IL HB1638
CONTROLLED SUB-SCHEDULE II
IL HB4834
CONTROLLED SUB-TESTOSTERONE
IL SB3323
CONTROLLED SUB-TESTOSTERONE
Similar Bills
VA HB998
Menstrual products ingredient labeling; restriction of substances, delayed effective date.
VA HB998
An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1, relating to menstrual products ingredient labeling; civil penalty.
NJ A1940
Requires ingredients of menstrual products to be listed on package.
IL HB5116
CONTROLLED SUB-PMP DATA
IL SB3521
CONTROLLED SUB-PMP DATA
FL S0876
Public Records and Public Meetings/Hearings Relating to Mental Health and Substance Abuse
NJ S3659
Creates registry of individuals who required medical assistance as result of misusing controlled dangerous substance.
NJ A1420
Establishes Office of Ombudsman for Mental Health and Addiction Services.